Desire for hastened death in advanced cancer: cross-sectional study in China

Feng Liu,Wanglian Peng,Ran Zhou,Xufen Huang,Hui Yang,Minni Wen,Lemeng zhang,Fei Tong,Desong Yang,Ling Jiang,Lili Yi,Xiaohong Liu
DOI: https://doi.org/10.1136/spcare-2022-003668
IF: 4.6332
2022-11-10
BMJ Supportive & Palliative Care
Abstract:Objective To evaluate the incidence of desire for hastened death (DHD) among patients with advanced cancer and to identify factors associated with DHD. Methods This was a cross-sectional study of 227 patients with advanced cancer in Hunan Cancer Hospital. The patients were assessed using Chinese version of the Schedule of Attitudes toward Hastened Death, Karnofsky Performance Scale, Quality of Life (QOL), MD Anderson Symptom Inventory and Patient Health Questionnaire Depression Module-9. Results The number of patients with or without DHD were 71 (31.3%) and 156 (68.7%), respectively. Follow-up visits and average and high QOL were protective factors for DHD; severely disturbed sleep, symptoms that severely interfered with mood, and symptoms that severely interfered with relations with other people were risk factors for DHD. Conclusions The incidence of the DHD in patients with advanced cancer at home is high. Those who have low QOL, severely disturbed sleep, symptoms that severely interfered with mood, or symptoms that severely interfered with relations with other people should be paid attention to. These data provide a theoretical basis for the early detection and diagnosis of the desire to accelerate death of patients with advanced cancer.
health care sciences & services
What problem does this paper attempt to address?